$NVLX ~ NEWS OUT...!!! Upcoming Q4 Events Bode Well for Nuvilex Shareholders ""On the micro front, Nuvilex investors may also be rewarded by upcoming milestones such as the pending closing of the diabetes technology treatment rights acquisition which was originally announced in 3Q13. This deal should immediately boost the Firm's valuation, upon closing. Plus, investors can expect to receive progress reports regarding the Firm's advanced clinical trials initiatives such as the production of the live cancer-drug-activating cells that will form part of the treatment to be used in its pancreatic cancer studies and the GMP facility in which the actual encapsulation of those cells will take place. "" http://finance.yahoo.com/news/upcoming-q4-eve...00893.html

Disclaimer: http://alturl.com/3yt3r